Analysis of IHC results of 40 samples found that the expression of PRMT6 in glioblastoma was significantly higher than that in LGG, and the expression of PRMT6 in invasive LGG was higher than that in non-invasive LGG (Fig. 1E, F). Here, PRMT6 is linked to glioblastoma.